Litcius/Paper detail

The secreted protein DEL-1 activates a β3 integrin–FAK–ERK1/2–RUNX2 pathway and promotes osteogenic differentiation and bone regeneration

Da‐Yo Yuh, Tomoki Maekawa, Xiaofei Li, Tetsuhiro Kajikawa, Khalil Bdeir, Triantafyllos Chavakis, George Hajishengallis

2020Journal of Biological Chemistry57 citationsDOIOpen Access PDF

Abstract

) and by mineralized nodule formation, depended on its capacity to induce the phosphorylation of focal adhesion kinase (FAK) and of extracellular signal-regulated kinase 1/2 (ERK1/2). We conclude that DEL-1 can activate a β3 integrin-FAK-ERK1/2-RUNX2 pathway in osteoprogenitors and promote new bone formation in mice. These findings suggest that DEL-1 may be therapeutically exploited to restore bone lost due to periodontitis and perhaps other osteolytic conditions.

Topics & Concepts

RUNX2Cell biologyIntegrinRGD motifChemistryExtracellular matrixMolecular biologyOsteoblastBiologyIn vitroReceptorBiochemistryCell Adhesion Molecules ResearchBlood disorders and treatmentsImmune Response and Inflammation
The secreted protein DEL-1 activates a β3 integrin–FAK–ERK1/2–RUNX2 pathway and promotes osteogenic differentiation and bone regeneration | Litcius